News

Proteomics International expands study with US big pharma

Proteomics International is pleased to announce its collaboration with Janssen Research & Development, LLC (Janssen) targeting diabetic kidney disease (DKD) treatment is progressing well and will now be expanded.

The collaboration is examining the performance of PromarkerD, our pioneering predictive test for diabetic kidney disease, in patients who have been treated in a Janssen completed clinical trial.

Media release

Subscribe
  • This field is for validation purposes and should be left unchanged.